Medicine and Dentistry
Albuminuria
10%
All Cause Mortality
27%
Biological Marker
9%
Blood Pressure
15%
Blood Vessel Calcification
11%
Body Mass Index
8%
Cardiovascular Disease
12%
Cardiovascular Mortality
9%
Cardiovascular Risk
7%
Cardiovascular System
16%
Chronic Kidney Disease
64%
Cohort Analysis
25%
Creatinine
9%
Disease
11%
End Stage Renal Disease
12%
Fibroblast Growth Factor 23
46%
Glomerular Filtration Rate
35%
Graft Failure
28%
Hazard Ratio
19%
Heart Failure
8%
Hyperparathyroidism
8%
Iron Deficiency
13%
Isotopes of Calcium
11%
Kidney Function
48%
Kidney Graft
100%
Kidney Injury
9%
Kidney Transplantation
41%
Linear Regression Analysis
7%
Maturity Onset Diabetes of the Young
15%
Nephropathy
15%
Osteocalcin
11%
Parathyroid Hormone
9%
Parathyroidectomy
12%
Placebo
15%
Population
27%
Potassium Intake
8%
Proportional Hazards Model
10%
Proteinuria
17%
Quality of Life
15%
Randomized Controlled Trial
11%
Renin Angiotensin Aldosterone System
15%
Sodium Excretion
8%
Sodium Intake
23%
Sodium Restriction
14%
Supplementation
18%
Terminal Illness
8%
Transplantation
12%
Urinary System
36%
Vitamin D
19%
Vitamin D Receptor
7%
Keyphrases
All-cause Mortality
22%
Biobank
16%
Blood Pressure
14%
Cardiovascular Mortality
12%
Chronic Kidney Disease
21%
Confidence Interval
12%
Death-censored Graft Survival
6%
Egfr
10%
End-organ Disease
9%
Erythropoietin
6%
Estimated Glomerular Filtration Rate
23%
Fibroblast Growth Factor 23 (FGF23)
40%
Free Thiols
7%
Glomerular Filtration Rate
8%
Graft Failure
11%
Graft Outcome
8%
Gut Microbiome
6%
Hazard Ratio
11%
Health-related Quality of Life
11%
High Risk
7%
Hypertension
9%
Incident Type 2 Diabetes
6%
Iron Deficiency
17%
Kidney
9%
Kidney Function
16%
Kidney Transplant Recipients
52%
Kidney Transplantation
20%
Late Graft Failure
6%
Living Kidney Donor
19%
Mortality Risk
8%
Netherlands
7%
New-onset Chronic Kidney Disease
6%
Phosphate
7%
Potential Confounders
10%
Pre-donation
9%
Pretransplant
8%
Prospective Cohort Study
10%
Proteinuria
12%
Proton Pump Inhibitors
8%
Renal Function
8%
Renal Transplant Recipients
18%
Renin-angiotensin-aldosterone System Blockade
7%
Serum Calcification Propensity
6%
Serum-free
7%
Transplantation
11%
Type 2 Diabetes Mellitus (T2DM)
21%
Type 2 Diabetic Patients
5%
Vitamin E
6%
Vitamin K
6%
Vitamin K Status
10%
Biochemistry, Genetics and Molecular Biology
All Cause Mortality
37%
Allele
6%
Arterial Stiffness
6%
Blood Level
6%
Blood Pressure
32%
C-Terminus
5%
Cardiovascular Mortality
15%
Cohort Study
27%
Creatinine
11%
Creatinine Blood Level
5%
Eicosanoid Receptor
5%
Erythropoietin
8%
Fibroblast Growth Factor 23
35%
Gene Locus
5%
Genetics
18%
Genome Wide Association Study
7%
Genome-Wide Association Study
13%
Glomerulus Filtration
35%
Hyperkalemia
5%
Iron Deficiency
12%
Kidney Function
47%
Magnesium Blood Level
7%
Magnesium Citrate
6%
Mendelian Randomization
9%
Metabolic Pathway
8%
N-Terminus
6%
Phosphate Blood Level
5%
Population
35%
Potassium Excretion
7%
Potassium Urine Level
6%
Prevalence
7%
Prospective Cohort Study
9%
Pulse Wave
5%
Randomized Controlled Trial
9%
Renin Angiotensin Aldosterone System
11%
Single Nucleotide Polymorphism
5%
Single-Nucleotide Polymorphism
6%
Sodium Excretion
5%
Systolic Blood Pressure
5%
Transferrin Saturation
5%
Urinary Excretion
7%
Vitamin D
26%
Vitamin K
12%
